Skip to content

Comparison Between Triphasic CT Abdomen and EUS-FNB in Characterization of Pancreatic Lesion

Comparison Between Triphasic CT Abdomen and EUS-FNB in Characterization of Pancreatic Lesion

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07424456
Enrollment
50
Registered
2026-02-20
Start date
2026-02-01
Completion date
2027-04-01
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CT Scan, EUS Guided Biopsy, Pancreatic Lesions Located at the Body or the Tail

Keywords

Triphasic Ct abdomen vs EUS-FNB, EUS-FNB

Brief summary

evaluate the relationship between triphasic CT and EUS findings and the characterization of pancreatic lesions.

Detailed description

Comparison Between Triphasic CT and EUS-FNB in characterization of Pancreatic Lesions

Interventions

DIAGNOSTIC_TESTFull clinical history (pain, jaundice, weight loss, pancreatitis history). Physical examination with focus on abdominal and systemic findings.

Full clinical history (pain, jaundice, weight loss, pancreatitis history). Physical examination with focus on abdominal and systemic findings.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \*Adult patients (age\>18 years) presenting with focal pancreatic lesions detected on initial imaging. * Patients referred for further evaluation by triphasic CT and/or EUS-guided biopsy. * Patients able to provide informed consent

Exclusion criteria

* Previous pancreatic surgery. * Known metastatic disease at presentation. * Contraindications to contrast-enhanced CT (e.g. severe renal impairment, contrast allergy) * Contraindications to EUS or biopsy (e.g., coagulopathy uncorrected, severe cardiopulmonary instability). * Pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy of triphasic CT compared to EUS-guided biopsy in differentiating benign from malignant pancreatic lesions.one yearthe diagnostic accuracy of triphasic CT compared to EUS-guided biopsy in differentiating benign and malignant pancreatic lesions, calculated in terms of sensitivity, specificity, PPV, NPV, and overall accuracy, using final histopathological diagnosis as the reference standard.

Contacts

CONTACTAhmed Abdullah Ashmawy, Prof. Dr
rasharma@aun.edu.eg01005679880
CONTACTMohamed Mahdy, ProfDr
drmohhakim@aun.edu.eg

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026